Key Metrics
Price Performance
30-DAY PRICE CHART
1-YEAR PERFORMANCE
Decision Support
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- UNH is valued near its sector range at 23.0x earnings versus 22.0x for peers, so the next move likely needs a real earnings or guidance catalyst.
- Recent realized volatility is running around 41.5%, above the sector norm of 22.0%, so position sizing matters more than usual.
- UNH is in a bullish short-term regime and only 48.9% below its 52-week high, so the question is whether fundamentals can keep pace with that stronger tape.
Portfolio Use Case
- UNH is more relevant for investors who want some income support alongside price appreciation, not just pure growth exposure.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in UNH.
- If the short-term trend rolls over while volume fades, the market may stop paying up for momentum before the fundamentals change.
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
Methodology
- Price, market cap, beta, yield, and liquidity fields for UNH come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as JNJ, PFE, ABBV.
Sources
Live quote, valuation, beta, yield, and volume fields used for UNH. Last refresh: Apr 13, 2026, 8:51 AM.
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
Comparative context for this page is anchored around nearby tracked names such as JNJ, PFE, ABBV.
Editorial note
Written by Portfolio Terminal Research. Template updated 3/24/2026, with market data refreshed from the latest feed on 4/13/2026, 8:51:42 AM. This page is designed for research workflow and portfolio monitoring, not personalized investment advice.
Healthcare Sector Context
Competitors Analysis
Technical Analysis
UnitedHealth Group is currently trading at $304.33, which is 48.9% below its 52-week high. With a beta of 0.41, the stock shows lower sensitivity to market movements.
Frequently Asked Questions
Is UNH a good buy right now?
UnitedHealth Group trades at 23.0x earnings. This is near market average. Current risk level is High based on 41.5% volatility.
Does UNH pay dividends?
Yes, UnitedHealth Group offers a dividend yield of 2.90%. This translates to approximately $8.83 per share annually.
How volatile is UNH?
With 30-day annualized volatility of 41.5% and beta of 0.41,UNH is classified as High risk. The stock tends to be more stable than the market average.
Related Assets
Track UNH Live
Add UnitedHealth Group to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALIMPORT BROKER FILE